ArticlePLoS neglected tropical diseases2026
Evaluation of mass dog vaccination campaign in Techiman, Ghana.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcross Sub-Saharan Africa, implementation of mass dog vaccination programmes is frequently constrained by inconsistent vaccine procurement, financing limitations, cold-chain requirements, and weaknesses in distribution systems, rather than complete vaccine unavailability. Achieving and sustaining at least 70% vaccination coverage in dog populations is widely recognized as essential for interrupting transmission; however, there is limited operational evidence from municipal campaigns conducted in rapidly urbanizing, resource-constrained settings. We evaluated the implementation and outcomes of a One Health-coordinated free mass dog rabies vaccination campaign conducted in September 2024 in Techiman South Metropolitan, Ghana. METHODOLOGY: A mixed-methods post-campaign assessment was undertaken two weeks after campaign completion. Quantitative data were collected from 200 dog-owning households using structured questionnaires, and administrative vaccination records were reviewed to estimate overall coverage. In addition, key informant interviews were conducted with veterinary officers, public health professionals, environmental health personnel, and community leaders involved in campaign delivery. Descriptive statistics were used to summarize household participation and awareness indicators, while qualitative data were analyzed thematically. PRINCIPAL
findingsAmong surveyed households, 59.5% owned more than one dog and 51.5% reported vaccinating at least one dog during the campaign. Awareness that rabies is fatal increased from 45% (self-reported pre-campaign recall) to 75% after the campaign period, while awareness that rabies is preventable increased from 40% to 70%. Administrative records indicated that approximately 5,600 dogs were vaccinated, corresponding to an estimated 70% metropolitan-level coverage based on projected dog population figures. Participants identified strong multisectoral collaboration and World Rabies Day mobilization as key facilitators. Implementation barriers included vaccine supply delays, limited cold-chain capacity, inadequate access for peri-urban communities, and the absence of strategies to vaccinate free-roaming dogs. CONCLUSIONS/SIGNIFICANCE: The evaluation demonstrated that the Techiman mass dog vaccination campaign achieved administrative vaccination coverage exceeding the internationally recommended threshold while identifying implementation barriers that may influence effective population immunity. The findings highlight the importance of improving vaccine logistics, expanding access to peri-urban communities, strengthening monitoring systems, and incorporating strategies for vaccinating free-roaming dogs during future campaigns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.